The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Malaria, Falciparum

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Malaria, Falciparum


Psychiatry related information on Malaria, Falciparum


High impact information on Malaria, Falciparum


Chemical compound and disease context of Malaria, Falciparum


Biological context of Malaria, Falciparum


Anatomical context of Malaria, Falciparum


Gene context of Malaria, Falciparum


Analytical, diagnostic and therapeutic context of Malaria, Falciparum


  1. Chloroquine treatment of severe malaria in children. Pharmacokinetics, toxicity, and new dosage recommendations. White, N.J., Miller, K.D., Churchill, F.C., Berry, C., Brown, J., Williams, S.B., Greenwood, B.M. N. Engl. J. Med. (1988) [Pubmed]
  2. Severe hypoglycemia and hyperinsulinemia in falciparum malaria. White, N.J., Warrell, D.A., Chanthavanich, P., Looareesuwan, S., Warrell, M.J., Krishna, S., Williamson, D.H., Turner, R.C. N. Engl. J. Med. (1983) [Pubmed]
  3. Trials of mefloquine in vivax and of mefloquine plus 'fansidar' in falciparum malaria. Harinasuta, T., Bunnag, D., Lasserre, R., Leimer, R., Vinijanont, S. Lancet (1985) [Pubmed]
  4. Activation of the host response in human Plasmodium falciparum malaria: relation of parasitemia to tumor necrosis factor/cachectin, thrombin-antithrombin III, and protein C levels. Hemmer, C.J., Kern, P., Holst, F.G., Radtke, K.P., Egbring, R., Bierhaus, A., Nawroth, P.P., Dietrich, M. Am. J. Med. (1991) [Pubmed]
  5. Malaria and onchocerciasis: On HLA and related matters. Meyer, C.G., Kremsner, P.G. Parasitol. Today (Regul. Ed.) (1996) [Pubmed]
  6. Resistance of glucose-6-phosphate dehydrogenase deficiency to malaria: effects of fava bean hydroxypyrimidine glucosides on Plasmodium falciparum growth in culture and on the phagocytosis of infected cells. Ginsburg, H., Atamna, H., Shalmiev, G., Kanaani, J., Krugliak, M. Parasitology (1996) [Pubmed]
  7. Acute psychosis after mefloquine: a case report. Sowunmi, A. East African medical journal. (1994) [Pubmed]
  8. A molecular marker for chloroquine-resistant falciparum malaria. Warhurst, D.C. N. Engl. J. Med. (2001) [Pubmed]
  9. Availability of intravenous quinidine for falciparum malaria. Rosenthal, P.J., Petersen, C., Geertsma, F.R., Kohl, S. N. Engl. J. Med. (1996) [Pubmed]
  10. Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion. Miller, K.D., Greenberg, A.E., Campbell, C.C. N. Engl. J. Med. (1989) [Pubmed]
  11. Tumor necrosis factor and disease severity in children with falciparum malaria. Grau, G.E., Taylor, T.E., Molyneux, M.E., Wirima, J.J., Vassalli, P., Hommel, M., Lambert, P.H. N. Engl. J. Med. (1989) [Pubmed]
  12. Blood glucose levels in Malawian children before and during the administration of intravenous quinine for severe falciparum malaria. Taylor, T.E., Molyneux, M.E., Wirima, J.J., Fletcher, K.A., Morris, K. N. Engl. J. Med. (1988) [Pubmed]
  13. Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies. Phillips, R.E., Warrell, D.A., White, N.J., Looareesuwan, S., Karbwang, J. N. Engl. J. Med. (1985) [Pubmed]
  14. Identification of a platelet membrane glycoprotein as a falciparum malaria sequestration receptor. Ockenhouse, C.F., Tandon, N.N., Magowan, C., Jamieson, G.A., Chulay, J.D. Science (1989) [Pubmed]
  15. Effectiveness and tolerance of long-term malaria prophylaxis with mefloquine. Need for a better dosing regimen. Lobel, H.O., Bernard, K.W., Williams, S.L., Hightower, A.W., Patchen, L.C., Campbell, C.C. JAMA (1991) [Pubmed]
  16. Invasion of mouse erythrocytes by the human malaria parasite, Plasmodium falciparum. Klotz, F.W., Chulay, J.D., Daniel, W., Miller, L.H. J. Exp. Med. (1987) [Pubmed]
  17. Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon. Ramharter, M., Kurth, F., Schreier, A.C., Nemeth, J., Glasenapp, I., Bélard, S., Schlie, M., Kammer, J., Koumba, P.K., Cisse, B., Mordmüller, B., Lell, B., Issifou, S., Oeuvray, C., Fleckenstein, L., Kremsner, P.G. J. Infect. Dis. (2008) [Pubmed]
  18. A molecular marker for chloroquine-resistant falciparum malaria. Djimdé, A., Doumbo, O.K., Cortese, J.F., Kayentao, K., Doumbo, S., Diourté, Y., Dicko, A., Su, X.Z., Nomura, T., Fidock, D.A., Wellems, T.E., Plowe, C.V., Coulibaly, D. N. Engl. J. Med. (2001) [Pubmed]
  19. Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies. Guevara Patiño, J.A., Holder, A.A., McBride, J.S., Blackman, M.J. J. Exp. Med. (1997) [Pubmed]
  20. Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes. Jensen, A.T., Magistrado, P., Sharp, S., Joergensen, L., Lavstsen, T., Chiucchiuini, A., Salanti, A., Vestergaard, L.S., Lusingu, J.P., Hermsen, R., Sauerwein, R., Christensen, J., Nielsen, M.A., Hviid, L., Sutherland, C., Staalsoe, T., Theander, T.G. J. Exp. Med. (2004) [Pubmed]
  21. Quinine and severe falciparum malaria in late pregnancy. Looareesuwan, S., Phillips, R.E., White, N.J., Kietinun, S., Karbwang, J., Rackow, C., Turner, R.C., Warrell, D.A. Lancet (1985) [Pubmed]
  22. The effect of X chromosome inactivation on the inhibition of Plasmodium falciparum malaria growth by glucose-6-phosphate-dehydrogenase-deficient red cells. Roth, E.F., Raventos Suarez, C., Rinaldi, A., Nagel, R.L. Blood (1983) [Pubmed]
  23. Thrombospondin binds falciparum malaria parasitized erythrocytes and may mediate cytoadherence. Roberts, D.D., Sherwood, J.A., Spitalnik, S.L., Panton, L.J., Howard, R.J., Dixit, V.M., Frazier, W.A., Miller, L.H., Ginsburg, V. Nature (1985) [Pubmed]
  24. Intracellular structures of normal and aberrant Plasmodium falciparum malaria parasites imaged by soft x-ray microscopy. Magowan, C., Brown, J.T., Liang, J., Heck, J., Coppel, R.L., Mohandas, N., Meyer-Ilse, W. Proc. Natl. Acad. Sci. U.S.A. (1997) [Pubmed]
  25. IFN-gamma and IL-10 mediate parasite-specific immune responses of cord blood cells induced by pregnancy-associated Plasmodium falciparum malaria. Brustoski, K., Möller, U., Kramer, M., Petelski, A., Brenner, S., Palmer, D.R., Bongartz, M., Kremsner, P.G., Luty, A.J., Krzych, U. J. Immunol. (2005) [Pubmed]
  26. Plasmodium falciparum Malaria: reduction of endothelial cell apoptosis in vitro. Hemmer, C.J., Lehr, H.A., Westphal, K., Unverricht, M., Kratzius, M., Reisinger, E.C. Infect. Immun. (2005) [Pubmed]
  27. PECAM-1/CD31, an endothelial receptor for binding Plasmodium falciparum-infected erythrocytes. Treutiger, C.J., Heddini, A., Fernandez, V., Muller, W.A., Wahlgren, M. Nat. Med. (1997) [Pubmed]
  28. Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway. Pichyangkul, S., Yongvanitchit, K., Kum-arb, U., Hemmi, H., Akira, S., Krieg, A.M., Heppner, D.G., Stewart, V.A., Hasegawa, H., Looareesuwan, S., Shanks, G.D., Miller, R.S. J. Immunol. (2004) [Pubmed]
  29. Endogenous interleukin-10 modulates proinflammatory response in Plasmodium falciparum malaria. Ho, M., Schollaardt, T., Snape, S., Looareesuwan, S., Suntharasamai, P., White, N.J. J. Infect. Dis. (1998) [Pubmed]
  30. Sequence variations in the genes encoding dihydropteroate synthase and dihydrofolate reductase and clinical response to sulfadoxine-pyrimethamine in patients with acute uncomplicated falciparum malaria. Basco, L.K., Tahar, R., Keundjian, A., Ringwald, P. J. Infect. Dis. (2000) [Pubmed]
  31. Analysis of Sepik populations of Papua New Guinea suggests an increase of CYP2C19 null allele frequencies during the colonization of Melanesia. Masta, A., Lum, J.K., Tsukahara, T., Hwaihwanje, I., Kaneko, A., Paniu, M.M., Sapuri, M., Takahashi, N., Ishizaki, T., Kobayakawa, T., Hombhanje, F.W. Pharmacogenetics (2003) [Pubmed]
  32. Quinidine in falciparum malaria. White, N.J., Looareesuwan, S., Warrell, D.A., Chongsuphajaisiddhi, T., Bunnag, D., Harinasuta, T. Lancet (1981) [Pubmed]
  33. Sequestrin, a CD36 recognition protein on Plasmodium falciparum malaria-infected erythrocytes identified by anti-idiotype antibodies. Ockenhouse, C.F., Klotz, F.W., Tandon, N.N., Jamieson, G.A. Proc. Natl. Acad. Sci. U.S.A. (1991) [Pubmed]
  34. Prevention of malaria. Keystone, J.S. Drugs (1990) [Pubmed]
  35. Clinical pharmacokinetics of halofantrine. Karbwang, J., Na Bangchang, K. Clinical pharmacokinetics. (1994) [Pubmed]
  36. Pathogen genotyping in polyclonal infections: application of a fluorogenic polymerase-chain-reaction assay in malaria. Decuypere, S., Elinck, E., Van Overmeir, C., Talisuna, A.O., D'Alessandro, U., Dujardin, J.C. J. Infect. Dis. (2003) [Pubmed]
WikiGenes - Universities